SCM
ASLN

Silverarc Capital Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Silverarc Capital Management’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,500
Closed -$1.59K – 83
2022
Q1 		$1.59K Sell
12,500
-24,955
-67% -$928K 0.66% 39
2021
Q4 		$1.68M Buy
+37,455
New +$2.25M 0.68% 42

Other funds holding ASLN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Silverarc Capital Management's ASLN Position: Q2 2022 in Review

Silverarc Capital Management sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q2 2022, closing a stake of 12,500 shares — an estimated $1.59K sold.

Silverarc Capital Management first reported a position in ASLN in Q4 2021 and held it in 2 quarters. The position peaked at $1.68M in Q4 2021. 27 funds tracked by Wall St. Rank hold ASLN as of Q2 2022.

  • Silverarc Capital Management reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Silverarc Capital Management sold 12,500 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q2 2022, an estimated $1.59K.
  • Silverarc Capital Management first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q4 2021 and held it in 2 quarters.
  • Silverarc Capital Management's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $1.68M in Q4 2021.
  • 27 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q2 2022.

Based on Silverarc Capital Management's 13F filing for Q2 2022, filed 25 Jul 2022.